# Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

> **NCT02057029** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 96 (actual)

## Conditions studied

- Breast Cancer
- Early Stage Estrogen Receptor (ER) Positive Breast Cancer

## Interventions

- **BEHAVIORAL:** BCI Assay Results

## Key facts

- **NCT ID:** NCT02057029
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2016-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02057029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02057029, "Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02057029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*